New amendment allows BC optometrists treat glaucoma

Article

The British Columbia Association of Optometrists (BCAO) has added to the Amendments to the Optometrists Regulation to allow optometrists to treat glaucoma.

In a move that will make the treatment of glaucoma easier and more efficient in British Columbia, BC Doctors of Optometry will now be able to prescribe medications for the treatment of glaucoma. The addition to the Amendments to the Optometrists Regulation started to take effect on August 2, 2012. Prior to this move, it wasn't uncommon for a patient to need to travel over one thousand kilometers to receive treatment for glaucoma.

Dr. Surginder Sahora, the president of the British Columbia Association of Optometrists (BCAO), commented on the change,

"By allowing Doctors of Optometry to prescribe anti-glaucoma medications, patients will have greater access to timely and appropriate eye care in all areas of the province. Doctors of Optometry are educated and certified to diagnose and to prescribe treatment for glaucoma. The recent changes allow them to practice what they are already certified to do."

For more information on the BC authorization to treat glaucoma, read the full press release.


Related Articles

British Columbia's optometrists are angling for glaucoma priviledges (May 1, 2012)

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Dr Neda Shamie speaks on cataract and refractive surgery at CIME 2025
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.